Canadians For Safe Access  
grassroots, action-oriented patient rights
 
 
Home >> Research >> Parkinson's

Cannabis Research - Parkinson's Disease


Survey on Cannabis Use in Parkinsonšs Disease: Subjective Improvement of Motor Symptoms: Paper read at 2003 Symposium on the Cannabinoids, at Cornwall, ON, Canada.
Abstract: An anonymous questionnaire sent to all patients attending the Prague Movement Disorder Centre revealed that 25% of 339 respondents had taken cannabis and 45.9% of these described some form of benefit.
Pertinent References:

Venderova, K., E. Ruzicka, V. Vorisek, and P. Visnovsky. 2003.

Russo, E. Neuroprotection/Degenerative Diseases

Consroe, P. 1998. Brain cannabinoid systems as targets for the therapy of neurological disorders. Neurobiol Dis 5 (6 Pt B):534-51.

Frankel, J. P., A. Hughes, A. J. Lees, and G. M. Stern. 1990. Marijuana for parkinsonian tremor. J Neurol Neurosurg Psychiatry 53 (5):436.

Glass, M. 2001. The role of cannabinoids in neurodegenerative diseases. Prog Neuropsychopharmacol Biol Psychiatry 25 (4):743-65.

Sieradzan, K. A., S. H. Fox, M. Hill, J. P. Dick, A. R. Crossman, and J. M. Brotchie. 2001. Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study. Neurology 57 (11):2108-11.

DOWNLOAD PDF: Survey on Cannabis Use in Parkinsonšs Disease: Subjective Improvement of Motor Symptoms